Clinical Trials in Anjo, Aichi

Find clinical trials in Anjo, Aichi. Discover local research opportunities and treatment options in your area.

5 Active Trials Found in Anjo

Showing 5 trials on this page

Page 1 of 1

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

NCT ID: NCT06158841

This clinical trial is studying a new treatment called ABBV-383 for adults with relapsed or refractory multiple myeloma, which is a type of blood cancer that affects plasma cells. The trial will co...

Recruiting

Phase: PHASE3 Conditions: Multiple Myeloma

Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma

NCT ID: NCT06356129

This clinical trial is studying a new treatment for patients with a type of cancer called high-risk large B-cell lymphoma (LBCL). Researchers want to see if adding a medication called golcadomide t...

Recruiting

Phase: PHASE3 Conditions: Large B-cell Lymphoma

A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

NCT ID: NCT06035497

This clinical trial is studying a new drug called BMS-986369 to see how safe it is, how well it works, and how much of the drug gets into the body in people with certain types of T-cell lymphomas t...

Recruiting

Phase: PHASE1 Conditions: Relapsed or Refractory T-cell Lymphomas

Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome

NCT ID: NCT05914155

This clinical trial is studying a treatment called rituximab for patients with idiopathic membranous nephropathy who also have nephrotic syndrome. Nephrotic syndrome is a condition where the kidney...

Recruiting

Phase: PHASE3 Conditions: Glomerulonephritis, Membranous, Nephrotic Syndrome，Idiopathic

Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure

NCT ID: NCT05392764

The EMPA-AHF trial is a clinical study investigating the effects of a medication called empagliflozin on patients who are hospitalized for acute heart failure (AHF) and are at high risk for serious...

Recruiting

Phase: PHASE3 Conditions: Acute Heart Failure

Search All Trials Browse All Locations